PerkinElmer

小動物活體成像索引

OF

臨床前活體成像用于轉化醫學研究

  • 臨床前活體成像用于新藥研發
  • 多模式活體成像幫助您同時獲取疾病相關的功能性與結構性.影像數據
  • 利用熒光手術導航成像系統,您可以便捷地找到腫瘤與正常組織邊緣,并輔助腫瘤的精確切除
  • 通過PET/CT,從不同角度解讀疾病及治療進程

?

聯系我們了解更多信息

僅供科學研究,非臨床診斷用途。

產品與服務 (109)
Filters:

Filters :

產品類型
  • Reagents (97)
  • Instruments (10)
  • Software and Informatics (2)
應用
  • In vivo imaging (1)
實驗類型
  • In vivo (1)
熒光劑類型
  • Targeted (18)
  • Labeling (15)
  • Vascular (10)
  • Activatable (9)
  • Cell labeling (2)
顯像模式
  • Fluorescence (56)
  • Bioluminenscence (38)
  • Optical Imaging (8)
  • microCT Imaging (2)
  • Chemilumiluminescence (2)
  • PET Imaging (1)
長度
  • 51-100 (6)
  • 41-50 (3)
  • 901-1000 (1)
產品品牌名稱
  • XenoLight (24)
  • Bioware Brite (20)
  • VivoTag (15)
  • IVIS (5)
  • Genhance (4)
  • RediFect (3)
  • ProSense (3)
  • IntegriSense (3)
  • FMT (3)
  • OsteoSense (3)
  • VivoTrack (2)
  • Cat B FAST (2)
  • Cat K FAST (1)
  • G-Platform (1)
  • MMPSense (1)
  • Superhance (1)
  • GFR-Vivo (1)
  • HypoxiSense (1)
  • FolateRSense (1)
  • Quantum (1)
  • GastroSense (1)
  • TLectinSense (1)
  • ReninSense (1)
  • BacteriSense (1)
治療領域
  • Oncology/Cancer (23)
  • Arthritis (19)
  • Inflammation (19)
  • Bacterial infection (18)
  • Atherosclerosis (15)
  • Angiogenesis (10)
  • Vascular disease (5)

1-12 的 109 產品與服務

  • Jump to:
Business Insights (11)
Filters:

Filters :

資源庫
  • Application Note (8)
  • Poster (3)

1-11 的 11 Business Insights

  • 應用文獻

    Imaging Hepatocellular Liver Injury using NIR-labeled Annexin V

    Drug induced liver injury (DILI) is a major reason for late stage termination of drug discovery research projects, highlighting the importance of early integration of liver safety assessment in the drug development process. A technical approach for in vivo toxicology determination was developed using Acetaminophen (APAP), a commonly used over-the-counter analgesic and antipyretic drug, to induce acute hepatocellular liver injury.

  • 應用文獻

    Preclinical Fluorescence Imaging of Cancer Metastasis to the Lung and Response to Therapy

    Quantitative pre-clinical fluorescence imaging transcends the boundaries of traditional optical imaging of biological structures and physiology by providing information at the molecular level about disease states and therapeutic response. Fluorescent Pre-clinical Imaging Agents and FMT? (Fluorescence Molecular Tomography) Quantitative Pre-clinical Imaging Systems represent powerful tools for research and drug development in the imaging of biological processes and pharmaceutical activity in living animals.

  • 應用文獻

    Stem Cell Research and Regenerative Medicine

    With the potential to treat a wide range of disease, from organ damage to congenital defects, stem cell research and tissue engineering form the underlying basis of regenerative medicine. Significant advances in the science of skin regeneration, for example, have now made it possible to develop and grow artificial skin grafts in a lab for treatment of burn victims. Other therapeutic applications include the use of stem cells to treat and repair central nervous system diseases such as ischemia and cerebral palsy, cardiovascular diseases, as well as autoimmune diseases including type I diabetes.

  • 應用文獻

    Multiplex 2D Imaging of NIR Molecular Imaging Agents on the IVIS SpectrumCT and FMT 4000

    Epifluorescence (2D) imaging of superficially implanted mouse tumor xenograft models offers a fast and simple method for assessing tumor progression or response to therapy. This approach for tumor assessment requires the use of near infrared (NIR) imaging agents specific for different aspects of tumor biology, and this Application Note highlights the ease and utility of multiplex NIR fluorescence imaging to characterize the complex biology within tumors growing in a living mouse.

  • 應用文獻

    Contrast-enhanced Imaging of Vasculature and Soft Tissues Using the Quantum GX MicroCT System

    X-ray CT imaging is commonly used for skeletal imaging as bones are densely mineralized tissues with excellent x-ray attenuation properties. In contrast, soft, less dense tissues often prove to be challenging to image due to their lack of sufficient tissue density. Soft tissues such as muscle, blood vessels and internal organs share similar x-ray attenuation characteristics and are not distinguishable under typical CT settings. In order to introduce density that would improve soft tissue contrast, several contrast agents have been developed for use in clinical and preclinical settings. This application note outlines the use of iodine and nanoparticle-based contrast agents for imaging soft tissues and vasculature in various organs using the Quantum GX to gain further insights into disease and therapeutic response.

  • 應用文獻

    MicroCT Investigation of Bone Erosion and Deformation in an Osteoarthritic Rat Model

    Osteoarthritis (OA) is the most common form of arthritis and affects a considerable portion of the elderly population. In the U.S., it is estimated that more than 630 million people worldwide have this chronic condition, generally in the knees. OA occurs when the cartilage that cushions the ends of bones within the joints gradually deteriorates, causing synovitis and joint deformation.

    The goal of OA research is to identify new therapeutic strategies that could prevent, reduce, halt progression, or repair the existing damage to the joint. Non-invasive in vivo imaging such as microCT is the standard modality for bone research due to its ability to obtain high-resolution images at an x-ray dose low enough as not to harm the animal. This makes microCT ideal for monitoring disease progression and response to treatments in the same animal over time. However, microCT data visualization and analysis can be cumbersome and time consuming. In this application note, we compared standard microCT software and advanced bone software to investigate bone erosion in an OA rat model.

  • 應用文獻

    Vascular Imaging Probes For Oncology and Inflammation Using the IVIS Spectrum

    Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. A number of fluorescent imaging probes that circulate with the blood, but have no target selectivity, have been used to detect tumor leakiness as an indication of abnormal tumor vasculature. Inflammation is also characterized by distinct vascular changes, including vasodilation and increased vascular permeability, which are induced by the actions of various inflammatory mediators. This process is essential for facilitating access for appropriate cells, cytokines, and other factors to tissue sites in need of healing or protection from infection. This application note investigates the use of three fluorescent imaging probes, to detect and monitor vascular leak and inflammation in preclinical mouse breast cancer models.

  • 應用文獻

    NIR Fluorescent Cell Labeling for In Vivo Cell Tracking (VivoTrack 680)

    Fluorescent dyes have been used for many years to label cells for microscopy studies, and a variety of dyes in the visible fluorescence spectrum are available to label different cellular compartments and organelles. Efficient delivery of the fluorophore to the cell without excessively modifying surface proteins or perturbing cell function is the major biotechnological challenge. In addition, researchers have taken on the challenge of in vivo imaging, focusing on near infrared (NIR) dyes that fluoresce in a spectral region better suited for in vivo imaging due to reduced background and higher tissue penetration.

  • 海報

    In vivo fluorescent imaging of tumor bombesin and transferrin receptor expression as early indicators of sorafenib efficacy in small animal models

    Targeted cancer therapy aims to block key signaling pathways that are critical for tumor cell growth and survival. The blockage eventually results in cell death via apoptosis and eventual tumor growth suppression. This strategy has proven to be quite effective, and the FDA has approved several targeted therapeutics in the past decade. Encouraged by the success in clinical development, many academic and pharmaceutical researchers are in active pursuit of improved next generation targeted anti-cancer drugs. As a result, many new chemical and biological entities are emerging from initial screening of in vitro, in vitro and/or in silico selection processes. From the perspective of drug development, it poses a great challenge for the next stage of in vivo validation and demands a robust, accurate, and efficient method for assessment of these candidates in living animal models.

  • 海報

    Molecular imaging of tumor energy metabolism as an early indicator of anti-cancer drug efficacy in small animal models

    Targeted cancer therapy aims to block key signaling pathways that are critical for tumor cell growth and survival. The blockage eventually results in cell death via apoptosis and tumor growth suppression. Encouraged by the success in clinical development, many academic and pharmaceutical researcher are in active pursuit of the improvement of next generation targeted anti-cancer drugs. As a result, many new chemical and biological entities are emerging from initial screening of in vitro, in vitro and/or in silico selection processes. From the perspective of drug development, it poses a great challenge on the next stage of in vivo validation and demands a robust, accurate, and efficient method for assessment of these candidates in living animal models.

  • 海報

    Combined efficacy & toxicity imaging following acute 5-FU treatment of HT-29 tumor xenografts

    Cancer chemotherapy can produce severe side effects such as suppression of immune function and damage to heart muscle, gastrointestinal tract, and liver. If serious enough, tissue injury can be a major reason for late stage termination of drug discovery research projects, so it is becoming more important to integrate safety/toxicology assessments earlier in the drug development process. There are a variety of traditional serum markers, tailored mechanistically to specific tissues, however there are no current non-invasive assessment tools that are capable of looking broadly at in situ biological changes in target and non-target tissue induced by chemical insult.

10分快3 沧州 | 靖江 | 垦利 | 抚州 | 嘉善 | 日土 | 乐平 | 如东 | 果洛 | 溧阳 | 五指山 | 迁安市 | 屯昌 | 普洱 | 三河 | 仁寿 | 钦州 | 张家口 | 葫芦岛 | 延安 | 张北 | 南通 | 株洲 | 衡阳 | 广元 | 黄山 | 许昌 | 如东 | 邹平 | 济南 | 泰州 | 和县 | 秦皇岛 | 乐山 | 通化 | 辽宁沈阳 | 迁安市 | 如皋 | 克拉玛依 | 雄安新区 | 资阳 | 如皋 | 抚顺 | 义乌 | 延边 | 石狮 | 南充 | 泰兴 | 灌南 | 防城港 | 任丘 | 雄安新区 | 大丰 | 河池 | 安阳 | 塔城 | 内江 | 九江 | 通辽 | 塔城 | 阳春 | 十堰 | 宝应县 | 果洛 | 张家口 | 枣庄 | 信阳 | 醴陵 | 海门 | 临沂 | 葫芦岛 | 泗阳 | 阿拉尔 | 无锡 | 牡丹江 | 如东 | 潜江 | 开封 | 吐鲁番 | 嘉善 | 西藏拉萨 | 嘉兴 | 临夏 | 和田 | 山南 | 甘孜 | 中山 | 北海 | 邢台 | 铜陵 | 济源 | 昌吉 | 平顶山 | 安岳 | 宣城 | 龙岩 | 宁德 | 宝应县 | 苍南 | 辽源 | 德清 | 厦门 | 张北 | 榆林 | 邹平 | 济南 | 东台 | 日土 | 深圳 | 阿拉善盟 | 崇左 | 自贡 | 梅州 |